Background: Alopecia areata (AA) is a common immune-mediated condition characterized by non-scarring hair loss. The aim of this study was to assess the plasma concentration level of Claudin 3 in patients with alopecia areata and its correlation with the disease severity. Methods: This study included 60 cases of alopecia areata of different types, and 20 apparently healthy volunteers as controls with matched age and sex. All groups were subjected to complete history taking, and through clinincal examination. Severity of AA lesions was assessed using
Abdallah, I., Abd Elaal, H., Khashaba, R., & El Salawy, D. (2021). Estimation of Claudin 3 in the Sreum of Alopecia Areata Patients and Its Association with Disease Severity. Benha Journal of Applied Sciences, 6(6), 263-266. doi: 10.21608/bjas.2021.214819
MLA
I.Y. Abdallah; H.E. Abd Elaal; R.A. Khashaba; D.A. El Salawy. "Estimation of Claudin 3 in the Sreum of Alopecia Areata Patients and Its Association with Disease Severity", Benha Journal of Applied Sciences, 6, 6, 2021, 263-266. doi: 10.21608/bjas.2021.214819
HARVARD
Abdallah, I., Abd Elaal, H., Khashaba, R., El Salawy, D. (2021). 'Estimation of Claudin 3 in the Sreum of Alopecia Areata Patients and Its Association with Disease Severity', Benha Journal of Applied Sciences, 6(6), pp. 263-266. doi: 10.21608/bjas.2021.214819
VANCOUVER
Abdallah, I., Abd Elaal, H., Khashaba, R., El Salawy, D. Estimation of Claudin 3 in the Sreum of Alopecia Areata Patients and Its Association with Disease Severity. Benha Journal of Applied Sciences, 2021; 6(6): 263-266. doi: 10.21608/bjas.2021.214819
)
View on SCiNiTO